Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Astria Therapeutics Q3 EPS $(0.87) Down From $(0.61) YoY

Astria Therapeutics (NASDAQ:ATXS) reported quarterly losses of $(0.87) per share. This is a 42.62 percent decrease over losses of $(0.61) per share from the same period last year.
byBenzinga Newsdesk
November 10, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Astria Therapeutics (NASDAQ:ATXS) reported quarterly losses of $(0.87) per share. This is a 42.62 percent decrease over losses of $(0.61) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Recap: Seacoast Banking Q2 Earnings

By Benzinga Insights
July 28, 4:38 PM
Seacoast Banking (NASDAQ:SBCF) reported its Q2 earnings results on Thursday, July 28, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Seacoast Banking beat estimated earnings by 11.32%, reporting an EPS of $0.59 versus an estimate of $0.53.

SBCF